Chris Estes

5.1k total citations · 1 hit paper
28 papers, 2.1k citations indexed

About

Chris Estes is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Chris Estes has authored 28 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Hepatology and 9 papers in Oncology. Recurrent topics in Chris Estes's work include Liver Disease Diagnosis and Treatment (10 papers), Colorectal Cancer Screening and Detection (9 papers) and Hepatitis B Virus Studies (5 papers). Chris Estes is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Colorectal Cancer Screening and Detection (9 papers) and Hepatitis B Virus Studies (5 papers). Chris Estes collaborates with scholars based in United States, Canada and Australia. Chris Estes's co-authors include Homie Razavi, Arun J. Sanyal, Rohit Loomba, Zobair M. Younossi, Kenneth A. Schmidt, Mark J. Spangehl, A. C. McLaren, Palak Trivedi, Kidist Yimam and Christopher L. Bowlus and has published in prestigious journals such as Gastroenterology, Hepatology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Chris Estes

26 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

2017 1.7k citations Chris Estes, Homie Razavi et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Estes United States	10	1.8k	988	563	355	296	28	2.1k
Andrei Racila United States	20	2.1k 1.2×	1.3k 1.3×	734 1.3×	367 1.0×	226 0.8×	55	2.4k
Mehmet Sayıner United States	16	1.4k 0.8×	872 0.9×	507 0.9×	260 0.7×	300 1.0×	27	1.9k
Issah Younossi United States	21	1.9k 1.1×	1.3k 1.4×	618 1.1×	324 0.9×	210 0.7×	45	2.2k
Raluca Pais France	21	1.9k 1.0×	865 0.9×	793 1.4×	332 0.9×	295 1.0×	59	2.3k
Janet C. Shaw United States	7	1.9k 1.1×	825 0.8×	855 1.5×	496 1.4×	281 0.9×	9	2.4k
Abdullah Al‐Osaimi United States	21	1.8k 1.0×	1.2k 1.2×	552 1.0×	627 1.8×	266 0.9×	42	2.3k
Joel Z. Stengel United States	5	1.6k 0.9×	702 0.7×	688 1.2×	299 0.8×	211 0.7×	6	1.9k
Francisco Barrera Chile	20	1.3k 0.7×	697 0.7×	437 0.8×	351 1.0×	207 0.7×	58	1.7k
Ibrahim Mostafa Egypt	13	1.3k 0.7×	633 0.6×	470 0.8×	449 1.3×	309 1.0×	28	1.9k
Claudia O. Zein United States	17	1.7k 1.0×	1.0k 1.0×	746 1.3×	381 1.1×	170 0.6×	32	2.1k

Countries citing papers authored by Chris Estes

Since Specialization

Citations

This map shows the geographic impact of Chris Estes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Estes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Estes more than expected).

Fields of papers citing papers by Chris Estes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Estes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Estes. The network helps show where Chris Estes may publish in the future.

Co-authorship network of co-authors of Chris Estes

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Estes. A scholar is included among the top collaborators of Chris Estes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Estes. Chris Estes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Estes, Chris, William K. Johnson, Michaël Doré, et al.. (2025). Multi-Target Stool DNA and the Fecal Immunochemical Test: A Systematic Review and Meta-Analysis on Test Performances. American Journal of Preventive Medicine. 69(2). 107654–107654. 1 indexed citations

Gamkrelidze, Ivane, et al.. (2025). Modeling the health and economic impact of pharmacologic therapies for MASLD in the United States. Journal of Hepatology. 83(1). 21–30. 7 indexed citations

Shaukat, Aasma, John B. Kisiel, Lyndon V. Hernandez, et al.. (2025). Environmental impact of colorectal cancer screening with colonoscopy and multi-target stool DNA (mt-sDNA) testing. Health Affairs Scholar. 3(3). qxaf041–qxaf041. 1 indexed citations

Fendrick, A. Mark, John B. Kisiel, Chris Estes, et al.. (2025). Evaluating benefit-to-burden ratios of the established and emerging colorectal cancer screening strategies. JNCI Journal of the National Cancer Institute. 117(12). 2653–2660. 1 indexed citations

Kisiel, John B., A. Mark Fendrick, Michaël Doré, et al.. (2025). Comparison of Benefit-to-Burden Ratios for Stool-Based Colorectal Cancer Screening Tests in the U.S.: A Decision Analytical Modeling Approach. AJPM Focus. 5(1). 100429–100429. 1 indexed citations

Estes, Chris, et al.. (2025). RE: Evaluating benefit-to-burden ratios of the established and emerging colorectal cancer screening strategies. JNCI Journal of the National Cancer Institute. 117(12). 2687–2688.

AlJaroudi, Wael, et al.. (2025). Childhood Obesity and Its Correlation With Vitamin D: A Systematic Review. Cureus. 17(5). e85047–e85047.

Kisiel, John B., A. Mark Fendrick, A. Burak Ozbay, et al.. (2024). Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening. Journal of Medical Economics. 27(1). 746–753. 5 indexed citations

Fendrick, A. Mark, John B. Kisiel, Chris Estes, et al.. (2024). Sa1144 ELIMINATING THE COLONOSCOPY BACKLOG WITH STOOL-BASED COLORECTAL CANCER SCREENING OPTIONS. Gastroenterology. 166(5). S–358. 1 indexed citations

10.

Razavi‐Shearer, Devin, Chris Estes, Ivane Gamkrelidze, & Homie Razavi. (2023). Cost‐effectiveness of treating all hepatitis B–positive individuals in the United States. Journal of Viral Hepatitis. 30(9). 718–726. 17 indexed citations

11.

Kisiel, John B., Lianne Barnieh, Nathaniel Smith, et al.. (2023). The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population. Journal of Medical Economics. 26(1). 1219–1226. 4 indexed citations

12.

Razavi‐Shearer, Devin, Ivane Gamkrelidze, Calvin Q. Pan, et al.. (2023). The impact of immigration on hepatitis B burden in the United States: a modelling study. The Lancet Regional Health - Americas. 22. 100516–100516. 14 indexed citations

13.

Biondi, Mia J., Chris Estes, Devin Razavi‐Shearer, et al.. (2023). Cost-effectiveness modelling of birth and infant dose vaccination against hepatitis B virus in Ontario from 2020 to 2050. CMAJ Open. 11(1). E24–E32. 3 indexed citations

14.

Blach, Sarah, Kimberly Brown, Robert S. Brown, et al.. (2022). Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress. Journal of Infection and Public Health. 16(1). 64–70. 7 indexed citations

15.

Estes, Chris, Henry Lik‐Yuen Chan, Rong‐Nan Chien, et al.. (2020). Modelling NAFLD disease burden in four Asian regions—2019‐2030. Alimentary Pharmacology & Therapeutics. 51(8). 801–811. 103 indexed citations

16.

Swain, Mark G., Alnoor Ramji, Keyur Patel, et al.. (2020). Burden of nonalcoholic fatty liver disease in Canada, 2019–2030: a modelling study. CMAJ Open. 8(2). E429–E436. 46 indexed citations

17.

Goossens, Nicolas, Stefano Bellentani, Andreas Cerny, et al.. (2019). Nonalcoholic fatty liver disease burden. Archive ouverte UNIGE (University of Geneva). 1 indexed citations

18.

Goossens, Nicolas, Stefano Bellentani, Andreas Cerny, et al.. (2019). Nonalcoholic fatty liver disease burden – Switzerland 2018–2030. Swiss Medical Weekly. 149(5152). w20152–w20152. 19 indexed citations

19.

Schmidt, Kenneth A., Chris Estes, A. C. McLaren, & Mark J. Spangehl. (2018). Chlorhexidine Antiseptic Irrigation Eradicates Staphylococcus epidermidis From Biofilm: An In Vitro Study. Clinical Orthopaedics and Related Research. 476(3). 648–653. 52 indexed citations

20.

Estes, Chris, Homie Razavi, Rohit Loomba, Zobair M. Younossi, & Arun J. Sanyal. (2017). Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 67(1). 123–133. 1686 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact